| 1BM7 | A:; B: | HUMAN TRANSTHYRETIN (PREALBUMIN) COMPLEX WITH FLUFENAMIC ACID (2-[[3-(TRIFLUOROMETHYL)PHENYL]AMINO] BENZOIC ACID) |
| 1BMZ | A:; B: | HUMAN TRANSTHYRETIN (PREALBUMIN) |
| 1BZ8 | A:; B: | TRANSTHYRETIN (DEL VAL122) |
| 1BZD | A:; B: | TERTIARY STRUCTURES OF THREE AMYLOIDOGENIC TRANSTHYRETIN VARIANTS AND IMPLICATIONS FOR AMYLOID FIBRIL FORMATION |
| 1BZE | A:; B: | TERTIARY STRUCTURES OF THREE AMYLOIDOGENIC TRANSTHYRETIN VARIANTS AND IMPLICATIONS FOR AMYLOID FIBRIL FORMATION |
| 1DVQ | A:; B: | CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN |
| 1DVS | A:; B: | CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH RESVERATROL |
| 1DVT | A:; B: | CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH FLURBIPROFEN |
| 1DVU | A:; B: | CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH DIBENZOFURAN-4,6-DICARBOXYLIC ACID |
| 1DVX | A:; B: | CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH DICLOFENAC |
| 1DVY | A:; B: | CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITH N-(M-TRIFLUOROMETHYLPHENYL) PHENOXAZINE-4,6-DICARBOXYLIC ACID |
| 1DVZ | A:; B: | CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH O-TRIFLUOROMETHYLPHENYL ANTHRANILIC ACID |
| 1E3F | A:; B: | STRUCTURE OF HUMAN TRANSTHYRETIN COMPLEXED WITH BROMOPHENOLS: A NEW MODE OF BINDING |
| 1E4H | A:; B: | STRUCTURE OF HUMAN TRANSTHYRETIN COMPLEXED WITH BROMOPHENOLS: A NEW MODE OF BINDING |
| 1E5A | A:; B: | STRUCTURE OF HUMAN TRANSTHYRETIN COMPLEXED WITH BROMOPHENOLS: A NEW MODE OF BINDING |
| 1ETA | 1:; 2: | THE X-RAY CRYSTAL STRUCTURE REFINEMENTS OF NORMAL HUMAN TRANSTHYRETIN AND THE AMYLOIDOGENIC VAL 30-->MET VARIANT TO 1.7 ANGSTROMS RESOLUTION |
| 1ETB | 1:; 2: | THE X-RAY CRYSTAL STRUCTURE REFINEMENTS OF NORMAL HUMAN TRANSTHYRETIN AND THE AMYLOIDOGENIC VAL 30-->MET VARIANT TO 1.7 ANGSTROMS RESOLUTION |
| 1F41 | A:; B: | CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN AT 1.5A RESOLUTION |
| 1F86 | A:; B: | TRANSTHYRETIN THR119MET PROTEIN STABILISATION |
| 1FH2 | A:; B: | TRANSTHYRETIN STABILITY AS A KEY FACTOR IN AMYLOIDOGENESIS |
| 1FHN | A:; B: | TRANSTHYRETIN STABILITY AS A KEY FACTOR IN AMYLOIDOGENESIS |
| 1G1O | A:; B:; C:; D: | CRYSTAL STRUCTURE OF THE HIGHLY AMYLOIDOGENIC TRANSTHYRETIN MUTANT TTR G53S/E54D/L55S |
| 1GKO | A:; B:; C:; D: | AN ENGINEERED TRANSTHYRETIN MONOMER THAT IS NON-AMYLOIDOGENIC - UNLESS PARTIALLY DENATURED |
| 1ICT | A:; B:; C:; D:; E:; F:; G:; H: | MONOCLINIC FORM OF HUMAN TRANSTHYRETIN COMPLEXED WITH THYROXINE (T4) |
| 1III | A:; B: | CRYSTAL STRUCTURE OF THE TRANSTHYRETIN MUTANT TTR Y114C-DATA COLLECTED AT ROOM TEMPERATURE |
| 1IIK | A:; B: | CRYSTAL STRUCTURE OF THE TRANSTHYRETIN MUTANT TTR Y114C-DATA COLLECTED AT CRYO TEMPERATURE |
| 1IJN | A:; B: | CRYSTAL STRUCTURE OF THE TRANSTHYRETIN MUTANT TTR C10A/Y114C |
| 1QAB | A:; B:; C:; D: | THE STRUCTURE OF HUMAN RETINOL BINDING PROTEIN WITH ITS CARRIER PROTEIN TRANSTHYRETIN REVEALS INTERACTION WITH THE CARBOXY TERMINUS OF RBP |
| 1QWH | A:; B: | A COVALENT DIMER OF TRANSTHYRETIN THAT AFFECTS THE AMYLOID PATHWAY |
| 1RLB | A:; B:; C:; D: | RETINOL BINDING PROTEIN COMPLEXED WITH TRANSTHYRETIN |
| 1SOK | A:; B: | CRYSTAL STRUCTURE OF THE TRANSTHYRETIN MUTANT A108Y/L110E SOLVED IN SPACE GROUP P21212 |
| 1SOQ | A:; B:; C:; D: | CRYSTAL STRUCTURE OF THE TRANSTHYRETIN MUTANT A108Y/L110E SOLVED IN SPACE GROUP C2 |
| 1THA | A:; B: | MECHANISM OF MOLECULAR RECOGNITION. STRUCTURAL ASPECTS OF 3, 3'-DIIODO-L-THYRONINE BINDING TO HUMAN SERUM TRANSTHYRETIN |
| 1THC | A:; B: | CRYSTAL STRUCTURE DETERMINATION AT 2.3A OF HUMAN TRANSTHYRETIN-3',5'-DIBROMO-2',4,4',6-TETRA-HYDROXYAURONE COMPLEX |
| 1TLM | A:; B: | STRUCTURAL ASPECTS OF INOTROPIC BIPYRIDINE BINDING: CRYSTAL STRUCTURE DETERMINATION TO 1.9 ANGSTROMS OF THE HUMAN SERUM TRANSTHYRETIN-MILRINONE COMPLEX |
| 1TSH | A:; B: | TERTIARY STRUCTURES OF THREE AMYLOIDOGENIC TRANSTHYRETIN VARIANTS AND IMPLICATIONS FOR AMYLOID FIBRIL FORMATION |
| 1TT6 | A:; B: | THE ORTHORHOMBIC CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITH DIETHYLSTILBESTROL |
| 1TTA | A:; B: | THE X-RAY CRYSTAL STRUCTURE REFINEMENTS OF NORMAL HUMAN TRANSTHYRETIN AND THE AMYLOIDOGENIC VAL30MET VARIANT TO 1.7 ANGSTROMS RESOLUTION |
| 1TTB | A:; B: | THE X-RAY CRYSTAL STRUCTURE REFINEMENTS OF NORMAL HUMAN TRANSTHYRETIN AND THE AMYLOIDOGENIC VAL30MET VARIANT TO 1.7 ANGSTROMS RESOLUTION |
| 1TTC | A:; B: | THE X-RAY CRYSTAL STRUCTURE REFINEMENTS OF NORMAL HUMAN TRANSTHYRETIN AND THE AMYLOIDOGENIC VAL30MET VARIANT TO 1.7 ANGSTROMS RESOLUTION |
| 1TTR | A:; B: | TRANSTHYRETIN-V/122/I CARDIOMYOPATHIC MUTANT |
| 1TYR | A:; B: | TRANSTHYRETIN COMPLEX WITH RETINOIC ACID |
| 1TZ8 | A:; B:; C:; D: | THE MONOCLINIC CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITH DIETHYLSTILBESTROL |
| 1U21 | A:; B: | TRANSTHYRETIN WITH TETHERED INHIBITOR ON ONE MONOMER. |
| 1X7S | A:; B: | THE X-RAY CRYSTALLOGRAPHIC STRUCTURE OF THE AMYLOIDOGENIC VARIANT TTR TYR78PHE |
| 1X7T | A:; B: | STRUCTURE OF TTR R104H: A NON-AMYLOIDOGENIC VARIANT WITH PROTECTIVE CLINICAL EFFECTS |
| 1Y1D | A:; B: | CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITH IODODIFLUNISAL |
| 1Z7J | A:; B: | HUMAN TRANSTHYRETIN (ALSO CALLED PREALBUMIN) COMPLEX WITH 3, 3',5,5'-TETRAIODOTHYROACETIC ACID (T4AC) |
| 1ZCR | A:; B: | CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN WITH BOUND IODIDE |
| 1ZD6 | A:; B: | CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN WITH BOUND CHLORIDE |
| 2B14 | A:; B: | THE CRYSTAL STRUCTURE OF 2,4-DINITROPHENOL IN COMPLEX WITH THE AMYLOIDOGENIC VARIANT TRANSTHYRETIN LEU 55 PRO |
| 2B15 | A:; B: | THE CRYSTAL STRUCTURE OF 2,4-DINITROPHENOL IN COMPLEX WITH HUMAN TRANSTHYRETIN |
| 2B16 | A:; B: | THE CRYSTAL STRUCTURE OF 2,4-DINITROPHENOL IN COMPLEX WITH THE AMYLOIDOGENIC VARIANT TRANSTHYRETIN TYR78PHE |
| 2B77 | A:; B: | HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH DIFLUNISAL ANALOGUES- TTR.2', 4'-DICHLORO-4-HYDROXY-1,1'-BIPHENYL-3-CARBOXYLIC ACID |
| 2B9A | A:; B: | HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH DIFLUNISAL ANALOGUES- TTR.3', 5'-DIFLUOROBIPHENYL-4-CARBOXYLIC ACID |
| 2F7I | A:; B: | HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH DIFLUNISAL ANALOGUES- TTR. 2',6'-DIFLUOROBIPHENYL-4-CARBOXYLIC ACID |
| 2F8I | A:; B: | HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH BENZOXAZOLE |
| 2FBR | A:; B: | HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH BIVALANT AMYLOID INHIBITOR (4 CARBON LINKER) |
| 2FLM | A:; B: | HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH BIVALANT AMYLOID INHIBITOR (6 CARBON LINKER) |
| 2G3X | A:; B: | CRYSTAL STRUCTURE OF TRANSTHYRETIN MUTANT I84S AT ACIDIC PH |
| 2G3Z | A:; B: | CRYSTAL STRUCTURE OF TRANSTHYRETIN MUTANT I84A AT LOW PH |
| 2G4E | A:; B: | CRYSTAL STRUCTURE OF TRANSTHYRETIN MUTANT I84A AT NEUTRAL PH |
| 2G4G | A:; B: | CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN AT PH 4.6 |
| 2G5U | A:; B: | HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH HYDROXYLATED POLYCHLORINATED BIPHENYL-4,4'-DIHYDROXY-3,3',5,5'-TETRACHLOROBIPHENYL |
| 2G9K | A:; B: | HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH HYDROXYLATED POLYCHLORINATED BIPHENYL-4-HYDROXY-2',3,3',4',5-PENTACHLOROBIPHENYL |
| 2GAB | A:; B: | HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH HYDROXYLATED POLYCHLORINATED BIPHENYL-4-HYDROXY-3,3',5,4'-TETRACHLOROBIPHENYL |
| 2H4E | A:; B: | CRYSTAL STRUCTURE OF CYS10 SULFONATED TRANSTHYRETIN |
| 2NOY | A:; B: | CRYSTAL STRUCTURE OF TRANSTHYRETIN MUTANT I84S AT PH 7.5 |
| 2PAB | A:; B: | STRUCTURE OF PREALBUMIN, SECONDARY, TERTIARY AND QUATERNARY INTERACTIONS DETERMINED BY FOURIER REFINEMENT AT 1.8 ANGSTROMS |
| 2QEL | A:; B:; C:; D: | CRYSTAL STRUCTURE OF THE HIGHLY AMYLOIDOGENIC TRANSTHYRETIN MUTANT TTR G53S/E54D/L55S- HEATED PROTEIN |
| 2QGB | A:; B: | HUMAN TRANSTHYRETIN (TTR) IN APO-FORM |
| 2QGC | A:; B: | HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH 2-(3,5-DIMETHYL-4-HYDROXYPHENYL)BENZOXAZOLE |
| 2QGD | A:; B: | HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH 2-(3,5-DIBROMO-4-HYDROXYPHENYL)BENZOXAZOLE |
| 2QGE | A:; B: | HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH 2-(3,5-DIMETHYLPHENYL) BENZOXAZOLE |
| 2ROX | A:; B: | TRANSTHYRETIN (ALSO CALLED PREALBUMIN) COMPLEX WITH THYROXINE (T4) |
| 2ROY | A:; B: | TRANSTHYRETIN (ALSO CALLED PREALBUMIN) COMPLEX WITH 3',5'-DINITRO-N-ACETYL-L-THYRONINE |
| 2TRH | A:; B: | TERTIARY STRUCTURES OF THREE AMYLOIDOGENIC TRANSTHYRETIN VARIANTS AND IMPLICATIONS FOR AMYLOID FIBRIL FORMATION |
| 2TRY | A:; B: | TERTIARY STRUCTURES OF THREE AMYLOIDOGENIC TRANSTHYRETIN VARIANTS AND IMPLICATIONS FOR AMYLOID FIBRIL FORMATION |
| 2WQA | A:; B:; C:; D: | COMPLEX OF TTR AND RBP4 AND OLEIC ACID |
| 3A4D | A:; B: | CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN (WILD-TYPE) |
| 3A4E | A:; B: | CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN (E54G) |
| 3A4F | A:; B: | CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN (E54K) |
| 3B56 | A:; B: | CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITH 3,5-DIIODOSALICYLIC ACID |
| 3BT0 | A:; B: | CRYSTAL STRUCTURE OF TRANSTHYRETIN VARIANT V20S |
| 3CBR | A:; B: | CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN (TTR) AT PH3.5 |
| 3CFM | A:; B: | CRYSTAL STRUCTURE OF THE APO FORM OF HUMAN WILD-TYPE TRANSTHYRETIN |
| 3CFN | A:; B: | CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH 1-ANILINO-8-NAPHTHALENE SULFONATE |
| 3CFQ | A:; B: | CRYSTAL STRUCTURE OF HUMAN WILD-TYPE TRANSTHYRETIN IN COMPLEX WITH DICLOFENAC |
| 3CFT | A:; B: | CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH 1-AMINO-5-NAPHTHALENE SULFONATE |
| 3CN0 | A:; B: | HUMAN TRANSTHYRETIN (TTR) IN COMPLEX WITH 3,5-DIMETHYL-4-HYDROXYSTILBENE |
| 3CN1 | A:; B: | HUMAN TRANSTHYRETIN (TTR) IN COMPLEX WITH 3,5-DIBROMO-4-HYDROXYSTILBENE |
| 3CN2 | A:; B: | HUMAN TRANSTHYRETIN (TTR) IN COMPLEX WITH 3,5-DIBROMO-4-HYDROXYBIPHENYL |
| 3CN3 | A:; B: | HUMAN TRANSTHYRETIN (TTR) IN COMPLEX WITH 1,3-DIBROMO-2-HYDROXY-5-PHENOXYBENZENE |
| 3CN4 | A:; B: | HUMAN TRANSTHYRETIN (TTR) IN COMPLEX WITH N-(3,5-DIBROMO-4-HYDROXYPHENYL)BENZAMIDE |
| 3CXF | A:; B: | CRYSTAL STRUCTURE OF TRANSTHYRETIN VARIANT Y114H |
| 3D2T | A:; B: | HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH DIFLUNISAL |
| 3D7P | A:; B: | CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN (TTR) AT PH 4.0 |
| 3DGD | A:; B:; C:; D: | CRYSTAL STRUCTURE OF THE F87M/L110M MUTANT OF HUMAN TRANSTHYRETIN AT PH 4.6 |
| 3DJR | A:; B: | CRYSTAL STRUCTURE OF TRANSTHYRETIN VARIANT L58H AT NEUTRAL PH |
| 3DJS | A:; B: | CRYSTAL STRUCTURE OF TRANSTHYRETIN VARIANT L58H AT ACIDIC PH |
| 3DJT | A:; B: | CRYSTAL STRUCTURE OF TRANSTHYRETIN VARIANT V30M AT ACIDIC PH |
| 3DJZ | A:; B: | CRYSTAL STRUCTURE OF TRANSTHYRETIN VARIANT L55P AT NEUTRAL PH |
| 3DK0 | A:; B: | CRYSTAL STRUCTURE OF TRANSTHYRETIN VARIANT L55P AT ACIDIC PH |
| 3DK2 | A:; B: | CRYSTAL STRUCTURE OF TRANSTHYRETIN VARIANT Y114H AT ACIDIC PH |
| 3DO4 | A:; B:; C:; D:; E:; F:; G:; H: | CRYSTAL STRUCTURE OF TRANSTHYRETIN VARIANT T60A AT ACIDIC PH |
| 3ESN | A:; B: | HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH N-(3,5-DIBROMO-4-HYDROXYPHENYL)-2,6-DIMETHYLBENZAMIDE |
| 3ESO | A:; B: | HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH N-(3,5-DIBROMO-4-HYDROXYPHENYL)-2,5-DICHLOROBENZAMIDE |
| 3ESP | A:; B: | HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH N-(3,5-DIBROMO-4-HYDROXYPHENYL)-3,5-DIMETHYL-4-HYDROXYBENZAMIDE |
| 3FC8 | A:; B: | CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITH IODODIFLUNISAL-BETAALAOME |
| 3FCB | A:; B: | CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITH IODODIFLUNISAL-BETAALAOH |
| 3GLZ | A:; B: | HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH(E)-3-(2-(TRIFLUOROMETHYL)BENZYLIDENEAMINOOXY)PROPANOIC ACID (INHIBITOR 11) |
| 3GPS | A:; B:; C:; D: | CRYSTAL STRUCTURE OF THE F87M/L110M MUTANT OF HUMAN TRANSTHYRETIN AT PH 5.5 |
| 3GRB | A:; B:; C:; D: | CRYSTAL STRUCTURE OF THE F87M/L110M MUTANT OF HUMAN TRANSTHYRETIN AT PH 6.5 |
| 3GRG | A:; B:; C:; D: | CRYSTAL STRUCTURE OF THE F87M/L110M MUTANT OF HUMAN TRANSTHYRETIN AT PH 7.5 |
| 3GS0 | A:; B: | HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH (S)-3-(9H-FLUOREN-9-YLIDENEAMINOOXY)-2-METHYLPROPANOIC ACID (INHIBITOR 16) |
| 3GS4 | A:; B: | HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH 3-(9H-FLUOREN-9-YLIDENEAMINOOXY)PROPANOIC ACID (INHIBITOR 15) |
| 3GS7 | A:; B: | HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH (E)-3-(2-METHOXYBENZYLIDENEAMINOOXY)PROPANOIC ACID (INHIBITOR 13) |
| 3HJ0 | A:; B: | TRANSTHYRETIN IN COMPLEX WITH A COVALENT SMALL MOLECULE KINETIC STABILIZER |
| 3I9A | A:; B: | CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN VARIANT A25T - #1 |
| 3I9I | A:; B: | CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN VARIANT A25T - #2 |
| 3IMR | A:; B: | TRANSTHYRETIN IN COMPLEX WITH (E)-2,6-DIBROMO-4-(2,6-DICHLOROSTYRYL)PHENOL |
| 3IMS | A:; B: | TRANSTHYRETIN IN COMPLEX WITH 2,6-DIBROMO-4-(2,6-DICHLOROPHENETHYL)PHENOL |
| 3IMT | A:; B: | TRANSTHYRETIN IN COMPLEX WITH (E)-4-(4-AMINOSTYRYL)-2,6-DIBROMOPHENOL |
| 3IMU | A:; B: | TRANSTHYRETIN IN COMPLEX WITH (E)-4-(3-AMINOSTYRYL)-2,6-DIBROMOANILINE |
| 3IMV | A:; B: | TRANSTHYRETIN IN COMPLEX WITH (E)-4-(4-AMINOSTYRYL)-2,6-DIBROMOANILINE |
| 3IMW | A:; B: | TRANSTHYRETIN IN COMPLEX WITH (E)-2,6-DIBROMO-4-(2,6-DIMETHOXYSTYRYL)ANILINE |
| 3IPB | A:; B: | HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH A PALINDROMIC BIVALENT AMYLOID INHIBITOR (11 CARBON LINKER). |
| 3IPE | A:; B: | HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH A PALINDROMIC BIVALENT AMYLOID INHIBITOR (7 CARBON LINKER). |
| 3KGS | A:; B: | V30M MUTANT HUMAN TRANSTHYRETIN (TTR) (APOV30M) PH 7.5 |
| 3KGT | A:; B: | V30M MUTANT HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH GENISTEIN (V30M:GEN) PH 7.5 |
| 3KGU | A:; B: | WILD TYPE HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH GENISTEIN (TTRWT:GEN) PH 7.5 |
| 3M1O | A:; B: | HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH 2-((3,5-DICHLORO-4-HYDROXYPHENYL)AMINO)BENZOIC ACID |
| 3NEE | A:; B: | WILD TYPE HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH GC-1 (TTRWT:GC-1) |
| 3NEO | A:; B: | WILD TYPE HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH GC-24 (TTRWT:GC-24) |
| 3NES | A:; B: | V30M MUTANT HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH GC-1 (V30M:GC-1) |
| 3NEX | A:; B: | V30M MUTANT HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH GC-24 (V30M:GC-24) |
| 3NG5 | A:; B: | CRYSTAL STRUCTURE OF V30M TRANSTHYRETIN COMPLEXED WITH (-)-EPIGALLOCATECHIN GALLATE (EGCG) |
| 3OZK | A:; B: | CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN VARIANT A25T IN COMPLEX WITH THYROXINE (T4) |
| 3OZL | A:; B: | CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN VARIANT A25T IN COMPLEX WITH FLUFENAMIC ACID. |
| 3P3R | A:; B: | TRANSTHYRETIN IN COMPLEX WITH (3,4-DIHYDROXY-5-NITROPHENYL)(2-FLUOROPHENYL)METHANONE |
| 3P3S | A:; B: | HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH (Z)-5-(3,5-DIBROMO-4-HYDROXYBENZYLIDENE)-IMINO-1-METHYLIMIDAZOLIDIN-4-ONE |
| 3P3T | A:; B: | HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH 4-(3-(2-FLOUROPHENOXY) PROPYL)-3,5-DIMETHYL-1H-PYRAZOLE |
| 3P3U | A:; B: | HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH 5-(2-ETHOXYPHENYL)-3-(PYRIDIN-4-YL)-1,2,4-OXADIAZOLE |
| 3SSG | A: | STRUCTURE OF TRANSTHYRETIN L55P IN COMPLEX WITH ZN |
| 3TCT | A:; B: | STRUCTURE OF WILD-TYPE TTR IN COMPLEX WITH TAFAMIDIS |
| 3TFB | A:; B: | TRANSTHYRETIN NATURAL MUTANT A25T |
| 3U2I | A:; B: | X-RAY CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN AT ROOM TEMPERATURE |
| 3U2J | A:; B: | NEUTRON CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN |
| 3W3B | A:; B: | CRYSTAL STRUCTURE OF WILD-TYPE HUMAN TRANSTHYRETIN |
| 4ABQ | A:; B: | CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITH LIGAND C-1 |
| 4ABU | A:; B: | CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITH LIGAND C-2 |
| 4ABV | A:; B: | CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITH LIGAND C-3 |
| 4ABW | A:; B: | CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITH LIGAND C-6 |
| 4AC4 | A:; B: | CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITH LIGAND C-18 |
| 4ACT | A:; B: | CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITH LIGAND C-17 |
| 4DER | A:; B: | CRYSTAL STRUCTURE OF THE WILD TYPE TTR BINDING APIGENIN (TTRWT:API) |
| 4DES | A:; B: | CRYSTAL STRUCTURE OF THE WILD TYPE TTR BINDING CHRYSIN (TTRWT:CHR) |
| 4DET | A:; B: | CRYSTAL STRUCTURE OF THE WILD TYPE TTR BINDING KAEMPFEROL (TTRWT:KAE) |
| 4DEU | A:; B: | CRYSTAL STRUCTURE OF THE WILD TYPE TTR BINDING NARINGENIN (TTRWT:NAR) |
| 4DEW | A:; B: | CRYSTAL STRUCTURE OF THE WILD TYPE TTR BINDING LUTEOLIN (TTRWT:LUT) |
| 4FI6 | A:; B: | KINETIC STABILIZATION OF TRANSTHYRETIN THROUGH COVALENT MODIFICATION OF K15 BY 3-(5-(3,5-DICHLOROPHENYL)-1,3,4-OXADIAZOL-2-YL)-BENZENESULFONAMIDE |
| 4FI7 | A:; B: | KINETIC STABILIZATION OF TRANSTHYRETIN THROUGH COVALENT MODIFICATION OF K15 BY 3-(5-(3,5-DICHLORO-4-HYDROXYPHENYL)-1,3,4-OXADIAZOL-2-YL)-BENZENESULFONAMIDE |
| 4FI8 | A:; B: | KINETIC STABILIZATION OF TRANSTHYRETIN THROUGH COVALENT MODIFICATION OF K15 BY 4-BROMO-3-(5-(3,5-DICHLORO-4-HYDROXYPHENYL)-1,3,4-OXADIAZOL-2-YL)-BENZENESULFONAMIDE |
| 4HIQ | A:; B: | THE STRUCTURE OF V122I MUTANT TRANSTHYRETIN IN COMPLEX WITH AG10 |
| 4HIS | A:; B: | THE STRUCTURE OF V122I MUTANT TRANSTHYRETIN IN COMPLEX WITH TAFAMIDIS |
| 4HJS | A:; B: | KINETIC STABILIZATION OF TRANSTHYRETIN THROUGH COVALENT MODIFICATION OF K15 BY (E)-N-(4-(4-HYDROXY-3,5-DIMETHYLSTYRYL)ETHANESULFONAMIDE |
| 4HJT | A:; B: | KINETIC STABILIZATION OF TRANSTHYRETIN THROUGH COVALENT MODIFICATION OF K15 BY (E)-N-(4-(4-HYDROXY-3,5-DIMETHYLSTYRYL)PHENYL)PROPIONAMIDE |
| 4HJU | A:; B: | TRANSTHYRETIN IN COMPLEX WITH (E)-N-(3-(4-HYDROXY-3,5-DIMETHYLSTYRYL) PHENYL)ACRYLAMIDE |
| 4I85 | A:; B: | CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITH CHF5074 AT NEUTRAL PH |
| 4I87 | A:; B: | CRYSTAL STRUCTURE OF TTR VARIANT I84S IN COMPLEX WITH CHF5074 AT ACIDIC PH |
| 4I89 | A:; B: | CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITH DIFLUNISAL AT ACIDIC PH |
| 4IIZ | A:; B: | CRYSTAL STRUCTURE OF WILD-TYPE HUMAN TRANSTHYRETIN IN COMPLEX WITH LUMIRACOXIB |
| 4IK6 | A:; B: | CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH LUMIRACOXIB |
| 4IK7 | A:; B: | CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH INDOMETHACIN |
| 4IKI | A:; B: | CRYSTAL STRUCTURE OF WILD-TYPE HUMAN TRANSTHYRETIN IN COMPLEX WITH INDOMETHACIN |
| 4IKJ | A:; B: | CRYSTAL STRUCTURE OF WILD-TYPE HUMAN TRANSTHYRETIN IN COMPLEX WITH SULINDAC |
| 4IKK | A:; B: | CRYSTAL STRUCTURE OF WILD-TYPE HUMAN TRANSTHYRETIN IN COMPLEX WITH SULINDAC |
| 4IKL | A:; B: | CRYSTAL STRUCTURE OF WILD-TYPE HUMAN TRANSTHYRETIN IN COMPLEX WITH SULINDAC |
| 4KY2 | A:; B: | TRANSTHYRETIN IN COMPLEX WITH THE FLUORESCENT FOLDING SENSOR (E)-7-HYDROXY-3-(4-HYDROXY-3,5-DIMETHYLSTYRYL)-4-METHYL-2H-CHROMEN-2-ONE |
| 4L1S | A:; B: | COVALENT MODIFICATION OF TRANSTHYRETIN K15 BY YIELDING THE FLUORESCENT CONJUGATE (E)-3-(DIMETHYLAMINO)-5-(4-HYDROXY-3,5-DIMETHYLSTYRYL) BENZAMIDE |
| 4L1T | A:; B: | TRANSTHYRETIN IN COMPLEX WITH (E)-3-(DIMETHYLAMINO)-5-(4-HYDROXY-3,5-DIMETHYLSTYRYL)BENZOIC ACID |
| 4MRB | A:; B: | WILD TYPE HUMAN TRANSTHYRETIN PH 7.5 |
| 4MRC | A:; B: | HUMAN TRANSTHYRETIN SER52PRO MUTANT |
| 5TTR | A:; B:; C:; D:; E:; F:; G:; H: | LEU 55 PRO TRANSTHYRETIN CRYSTAL STRUCTURE |
)
)